Pioneering the Next Generation
of Precision ADC Therapeutics
Carl Gordon, Ph.D., C.F.A.
Chairman
© 2025 Sidewinder Therapeutics. All Rights Reserved. Terms of Use | Privacy Notice
About Sidewinder
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics.
We aim to deliver new life-saving therapies for patients with cancer and rare disease. Built by a dynamic team of serial entrepreneurs and expert scientists and drug developers, we are advancing innovative medicines targeting highly specific molecular drivers of disease.
Leadership Team
The Sidewinder Team has extensive experience in drug discovery and development and is committed to delivering therapies to improve the lives of patients.
Board of Directors
Ryan Corcoran, M.D., Ph.D.
Co-Founder & Director
Eric Murphy, Ph.D.
Chief Executive Officer,
Co-Founder, & Director
Our Investors
Eric Murphy, Ph.D.
/in Leadership TeamChief Executive Officer,
Co-Founder, & Director
Rob McRae
/in Leadership TeamPresident &
Chief Operating Officer
Patrick A. Zweidler-McKay, M.D., Ph.D.
/in Leadership TeamChief Medical Officer
Leslie Sharp, Ph.D.
/in Leadership TeamChief Scientific Officer
Michael Mueller
/in Leadership TeamGeneral Counsel